FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis

Abstract

Background and purposeBreast carcinoma is the most common cancer in female patients with a propensity for recurrence and metastases. The accuracy of ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), scintimammography (SMM) and positron emission tomography (PET) in diagnosing the recurrent and/or breast cancer has never been systematically assessed, and present systematic review was aimed at this issue.MethodsMEDLINE and EMBASE were searched for articles dealt with detection of recurrent and/or metastatic breast cancer by US, CT, MRI, SMM or PET whether interpreted with or without the use of CT. Histopathologic analysis and/or close clinical and imaging follow-up for at least 6 months were used as golden reference. We extracted data to calculate sensitivity, specificity, summary receiver operating characteristic curves and area under the curve and to test for heterogeneity.ResultIn 42 included studies, US and MRI had highest pooled specificity (0.962 and 0.929, respectively); MRI and PET had highest pooled sensitivity (0.9500 and 0.9530, respectively). The AUC of US, CT, MRI, SMM and PET was 0.9251, 0.8596, 0.9718, 0.9386 and 0.9604, respectively. Results of pairwise comparison between each modality demonstrated that AUC of MRI and PET was higher than that of US or CT, p < 0.05. No statistical significance was found between MRI and PET. There was heterogeneity among studies and evidence of publication bias.ConclusionIn conclusion, MRI seemed to be a more useful supplement to current surveillance techniques to assess patients with suspected recurrent and/or metastatic breast cancer. If MRI shows an indeterminate or benign lesion or MRI was not applicable, FDG-PET could be performed in addition.

18F-FDG PET/CT for Staging and Restaging of Breast Cancer

“…In the study by Schmidt et al, PET/CT was found to be more sensitive than WB MRI for the detection of lymph node involvement (n 5 21 vs. n 5 16); however, WB MRI was slightly more sensitive (n 5 154 vs. n 5 147) for the detection of distant metastases (26). Two metaanalyses compared 18 F-FDG PET/CT, conventional imaging (ultrasonography, CT, and bone scintigraphy), and MRI for the detection of breast cancer recurrence (48,49). PET/CT outperformed PET alone and conventional imaging but not MRI.…”

Prevalence of Depression in Breast Cancer Survivors: a Systematic Review of Observational Studies

“…During the follow-up care, survivors' psychological needs were often neglected (Park and Hwang, 2012). A main theme of depression among breast cancer survivors was the fear of breast cancer recurrence and metastasis (Pan et al, 2010). Long term effects associated with chemotherapy include infertility, sexual dysfunction, menopause-associated health problems e.g.…”

Positron Emission Tomography/Magnetic Resonance Imaging Practices in Oncological Imaging

“…Bu nedenle PET, difüzyon ağırlıklı ve perfüzyon MR görüntülemeden elde edilen sayısal parametrelerin, geleneksel kontrastlı meme MR'ı tamamlayıcı nitelikte bilgiler vermesi önem taşımaktadır. Hastalık rekürrensinin değerlendirilmesinde ise, yayımlanan bir metaanalize göre PET ve tüm vücut MR görüntüleme, ultrasonografi (USG) ve BT'ye üstündür (59). Hastalığın yeniden evrelenmesinde, lenf nodu tutulumunun değerlendirilmesinde FDG PET/BT daha yüksek duyarlılığa sahipken, tüm vücut MR görüntüleme daha fazla sayıda kemik, karaciğer ve beyin metastazı saptayabilmektedir (48).…”